Cardiomedex is a niche contract research organization (CRO) dedicated to examining the cardiovascular effects of drugs candidates. The company is based on a new concept: generate preclinical and early clinical proof-of concept evidence to optimize drug development.
We bring an innovative vision to research by combining key clinical pharmacology
skills with scientific expertise in cardiovascular diseases, onco-cardiology and
neurocardiology (autonomic dysfunction, ...).
Latest News
- 03.29.2012 The Cardiometabolic hub is launched!
- 12.16.2011 Cardiomedex unveils its website